Cardurion Pharmaceuticals
Cardurion Pharmaceuticals, Inc., located in Burlington, MA, is dedicated to transforming the treatment landscape for patients with cardiovascular disease through innovative pharmacological strategies targeting endothelial pathways. The company specializes in pioneering clinical programs addressing unmet needs in heart failure and various cardiovascular conditions via cutting-edge research and strategic industry partnerships.
With a seasoned team of cardiovascular experts, Cardurion is at the forefront of advancements in PDE9 and CaMKII inhibition, aiming to deliver breakthrough therapies that not only enhance treatment outcomes but also improve quality of life for patients with chronic cardiac issues. The organization's commitment to precision medicine and adaptive trial designs positions it as a leader in the next generation of cardiovascular innovation.
Generated from the website


